Dr Gregory Leyer

Chief Scientific Officer, UAS Labs

PANELLIST – Where are the growth opportunities in the microbiome, probiotics and prebiotics?

Greg has dedicated his professional career to probiotic advancement making him not only a critical component of UAS Labs but a world-renowned expert, educator and speaker in the field.  To continue driving the industry and UAS Labs forward, Greg continues research in the areas of probiotic bioprocess development, application development, and clinical sciences.  To-date he has authored or co-authored 24 publications in the areas of probiotic clinical results, application know-how, safety parameters, and holds patents in the field. In addition, he is an active member of both the International Probiotic Association (IPA) and International Scientific Association for Probiotics and Prebiotics (ISAPP).  A graduate of the University of Wisconsin-Madison, Greg received his MS and PhD in Food Microbiology and Toxicology studying the pathogenesis of various organisms including Clostridium botulinum and Salmonella typhimurium. His post-graduate career has since focused on the beneficial effects microbes have on humans.

Back to speakers
Back to programme